KR-Natural Products

AI-Driven Natural Product Intelligence Platform

KR-NATURAL PRODUCTS is a computational platform designed to transform biological and chemical data into actionable intelligence for natural product discovery, antimicrobial development, and biotechnology investment.

The platform focuses on mapping bioactive chemical space, predicting biosynthetic pathways, and modeling synergistic interactions among secondary metabolites, where efficacy is often driven by multi-compound systems rather than single molecules.

By integrating multimodal datasets spanning chemistry, biology, and biosynthetic information, KR-Natural Products enables:

• Generation of predictive models linking compound structure to biological function

• Mapping of biosynthetic pathways and enzyme-driven transformations

• Modeling of synergistic interactions across complex compound mixtures

• Development of structure–activity relationships across natural product classes

The platform powers two core capabilities:

1. Investment Decision Engine
   Enables biotech investors to evaluate natural product opportunities based on mechanistic robustness, probability of success, and system-level biological activity.

2. Discovery Engine
   Enables pharmaceutical and biotechnology teams to generate novel, biosynthetically plausible compounds, explore patentable chemical space, and design optimized multi-compound antimicrobial systems.

KR-NATURAL PRODUCTS does not function as a wet lab or data generation entity. Instead, it operates as the intelligence layer of the platform, leveraging structured datasets generated by Kaniszewski Laboratories to drive prediction, optimization, and decision-making.

Outputs from this platform support downstream validation and commercialization through MAACKII BIO and CANNA MAACKII, where software-guided discoveries are translated into scalable antimicrobial solutions across agriculture, human health, wildlife protection, food safety, and environmental systems.